Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	[1]
Current assets
Cash and cash equivalents	$ 80,386	$ 63,234
Short-term investments	356,221	431,011
Prepaid expenses and other current assets (Note 5)	10,946	11,257
Total current assets	447,553	505,502
Property and equipment, net (Note 4)	5,395	3,567
Operating lease right-of-use assets (Note 14)	28,863	1,211
Restricted cash	1,482	1,482
Other non-current assets	437	392
Total assets	483,730	512,154
Current liabilities
Accounts payable	3,247	4,531
Accrued research and development	19,383	12,456
Accrued liabilities (Note 6)	8,196	10,219
Operating lease liabilities, current (Note 14)	98	1,318
Total current liabilities	30,924	28,524
Operating lease liabilities, non-current (Note 14)	30,058	0
Long-term debt (Note 7)	30,070	10,054
Total liabilities	91,052	38,578
Commitments and Contingencies (Note 13)
Stockholders’ equity
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized at June 30, 2024 and December 31, 2023, and none issued or outstanding at June 30, 2024 and December 31, 2023 (Note 9)	0	0
Common stock, $0.0001 par value per share; 300,000,000 shares authorized at June 30, 2024 and December 31, 2023; and 60,425,144 and 59,921,002 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively; (Note 10)	6	6
Additional paid-in capital	995,846	972,973
Accumulated deficit	(602,557)	(499,748)
Accumulated other comprehensive (loss) gain	(617)	345
Total stockholders’ equity	392,678	473,576
Total liabilities and stockholders’ equity	$ 483,730	$ 512,154

[1] The condensed balance sheet as of December 31, 2023 has been derived from the audited financial statements as of that date.